newsfilter
← Latest News
GlobeNewswire·

Kyverna Therapeutics to Present at Upcoming Investor Conferences

EMERYVILLE, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (NASDAQ:KYTX), a late-stage clinical biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases,